UMass Chan and UMass Lowell’s point-of-care technology initiative awarded $8.9 million renewal - POCTRN
Center news
UMass Chan and UMass Lowell’s point-of-care technology initiative awarded $8.9 million renewal
The program aims to jumpstart new tools to address heart, lung, blood and sleep disorders, especially in underserved populations.
The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood and Sleep Disorders, created as an offshoot of a successful medical product incubator, the Massachusetts Medical Device Development Center (M2D2) at UMass Lowell and UMass Chan, is one of seven centers nationwide receiving new five-year awards as part of NIH’s Point of Care Technology Research Network (POCTRN).
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness